艾地苯醌治疗血管性痴呆疗效的Meta分析

• 药品评价-循证医学研究 • 上一篇下一篇

艾地苯醌治疗血管性痴呆疗效的Meta分析

赵俊杰,杨春华

周口市中心医院,周口市中心医院神经内一科

收稿日期:2018-06-04 修回日期:2018-06-04 出版日期:2018-08-25 发布日期:2018-08-25

Effectiveness of Idebenone in the Treatment of Vascular Dementia：A Meta Analysis

ZHAO Jun-jie and

Zhoukou Central Hospital,Department of Neurology,Zhoukou Central Hospital,Hennan Zhoukou;China

Received:2018-06-04 Revised:2018-06-04 Online:2018-08-25 Published:2018-08-25

摘要/Abstract

摘要： 目的：系统评价艾地苯醌治疗血管性痴呆的疗效。方法：计算机检索SCI、PubMed、EMBASE、Cochrane Library、中国生物医学文献数据库、中国知网数据库、万方数据库和维普数据库，收集所有艾地苯醌治疗血管性痴呆的随机对照试验，检索时限均从建库到2018年04月01日。2位研究者独立筛选文献、提取数据、评价文献质量后，采用STATA 15.0软件进行Meta分析。结果：共纳入11个研究 745例患者，Meta分析结果显示，艾地苯醌组的MMSE评分（WMD=2.28， 95% CI 1.82~2.75，P=0.000）、ADL评分（Barthel指数评分）（WMD=2.04， 95% CI 1.14~2.94， P=0.000）和总有效率（RR=1.15，95% CI 1.07~1.24，P=0.000）高于对照组，差异有统计学意义。结论：艾地苯醌能促进血管性痴呆患者的神经功能恢复，可用于血管性痴呆的治疗。 [关键词]艾地苯醌；血管性痴呆；Meta分析 [中图分类号]

Abstract: Objective：To systematically evaluate the effectiveness of idebenone versus conventional treatment for vascular dementia(VD). Methods： Systematic searches were conducted in SCI， PubMed， EMBASE， Cochrane Library， CBM， CNKI， WanFang， and VIP databases， to collect all relative randomized controlled trials (RCTs) on idebenone treating VD from inception to April 2018. Two reviewers independently screened articles according to the inclusion and exclusion criteria， extracted data and evaluated the quality of the included studies. Then statistical analysis was performed using STATA 15.0. Results：A total of 11 RCTs involving 745 patients were included. The results of meta-analysis demonstrated that compared with the control group ， the idebenone group was statistical significant higher in the MMSE score， Barthel index score， total effective rate， significant efficency. Conclusion： Current evidence showed idebenone promote recovery of neurological function in VD patients and can be used for VD treatment.

赵俊杰,杨春华. 艾地苯醌治疗血管性痴呆疗效的Meta分析[J]. .

ZHAO Jun-jie and. Effectiveness of Idebenone in the Treatment of Vascular Dementia：A Meta Analysis[J]. .

参考文献

[1]RizziL, RossetI, Roriz - Cruz M.Global epidemiologyofdementia:Alzheimers and vascular types [J]. BioMed research international, 2014,2014：908 -915.
[2]黄海华,李明秋等. 依达拉奉治疗轻、中度血管性痴呆56例观察[J].重庆医学,2011年11月第40卷第31期:3179-3180.
[3]王建新,金志敏,徐凯等.血管性痴呆治疗的研究新进展[J].临床合理用,2014年5月第7卷第5A期:192-193.
[4]王菲.血管性痴呆的分子机制及治疗学研究进展[J].中国神经精神疾病杂志,2014,40(5):317-320.
[5]Geerlings MI,Appelman AP,Vincken KL,et al.Association of white matter lesions and lacunar infarcts with executive functioning: the SMart MR study[J].Am J Epidemiol,200.
[6]Lin P.Idebenone protects against oxidized low density lipoprotein induced mitochondrial dysfunction in vascular endothelial cells via GSK3β/β-catenin signaling pathways[J].Biochemical Biophysical Research Communications,2015,465(3):548-555.
[7]Frew AJ．25 Immunotherapy of allergic disease[J]．Allergy Clin Immunol,2003,111(2 Suppl) : S712-719．
[8]李欣欣,张云云,王滨.艾地苯醌联合多奈哌齐治疗高龄血管性痴呆的研究[J].黑龙江医药科学, 2018,41(1):49-51.
[9]付晓雪,徐波,王笑嫔,等.艾地苯醌联合尼莫地平治疗脑梗死后血管性认知功能障碍的疗效观察[J].疑难病杂志,2016,15(2):119-122.
[10]张东坡,许小梅,施玉梅等.艾地苯醌与奥拉西坦治疗血管性痴呆临床研究[J].河北医药,2013,35(18):2769-2771.
[11]王广锋,毛洪兵.艾地苯醌与尼莫地平治疗血管性痴呆的临床疗效观察[J].国际医药卫生导报,2015,21(17):2596-2597.
[12]胡金城.艾地苯醌治疗血管性痴呆47例临床观察[J].吉林医学, 2014, 35(5):925-927.
[13]司克斌,李进兰.尼莫地平联合艾地苯醌治疗血管性痴呆的临床疗效[J].甘肃医药, 2010,29(2):132-134.
[14]陈笑英.长春西汀及艾地苯醌联合治疗慢性缺血性脑血管病的临床效果分析[J].中国实用神经疾病杂志,2016,19(14):59-59.
[15]金辉.长春西汀联合艾地苯醌治疗慢性缺血性脑血管病的疗效观察[J].中国实用医药,2016,11(1):118-119.
[16]陈斌,刘陈先,梁超越.长春西汀联合艾地苯醌治疗血管性痴呆的疗效观察[J].临床合理用药杂志, 2013, 6(11):18-19.
[17]潘丽雅,翁保慧,邓珊.艾地苯醌治疗非痴呆型血管认知功能障碍患者的临床观察[J].癫痫与神经电生理学杂志,2016,25(4):227-229.
[18]陈炳光,包泽岩.艾地苯醌治疗急性脑梗死合并认知功能障碍的临床效果分析[J].吉林医学, 2017,38(12):2283-2284.
[19]黄若燕.奥拉西坦联合尼莫地平治疗血管性痴呆49例疗效评价[J].中国实用医药,2013,8(11):36-37.
[20]Alagiakrishnan K,McCracken P,Feldman H． Treating vascular risk factors and maintaining vascular bealth: Is this the way towards successful cognitive ageing and preventing cognitive decline [J]．PostgradMed J,2006,82( 964) : 101-105．
[21]史德海,张卉田,赵梦杨等．认知功能训练联合尼莫地平对急性脑梗死认知功能障碍患者的影响[J]．中国实用神经病杂志,2010,13(24) :28-30．
[22]李欣欣,张云云,王滨.艾地苯醌联合多奈哌齐治疗高龄血管性痴呆的研究[J].黑龙江医药科学,2018,41(1):50-51.
[23]Abdelazim SA.Potential Antifibrotic and Angiostatic Impact of Idebenone,Carnosine and Vitamin E in Nano-Sized Titanium Dioxide-Induced Liver Injury[J]．Cellar Physiology Biochemistry International Journal of Experimental Cellular Physiology Biochemistry Pharmacology,2015,35(6):2402-2411．
[24]彭亮,赵鹏,李彬,张洁宏等.辅酶Q10的人体抗氧化作用研究[J].实用预防医学,2011,18 (8):1546-1548.
[25]陈炳光,包泽岩.艾地苯醌治疗急性脑梗死合并认识功能障碍的临床效果分析[J].吉林医学, 2017,38(12):2284.